Pages that link to "Q41092401"
Jump to navigation
Jump to search
The following pages link to Generalized lipodystrophy, congenital and acquired (lipoatrophy). (Q41092401):
Displaying 50 items.
- Surgical implantation of adipose tissue reverses diabetes in lipoatrophic mice (Q24620943) (← links)
- Mutations in Gng3lg and AGPAT2 in Berardinelli-Seip congenital lipodystrophy and Brunzell syndrome: phenotype variability suggests important modifier effects (Q24633634) (← links)
- Heterogeneity of white adipose tissue: molecular basis and clinical implications (Q26766498) (← links)
- New advances in the treatment of generalized lipodystrophy: role of metreleptin (Q26781946) (← links)
- Congenital generalized hypertrichosis: the skin as a clue to complex malformation syndromes (Q26799089) (← links)
- Inhibition of RXR and PPARgamma ameliorates diet-induced obesity and type 2 diabetes (Q28360697) (← links)
- Endogenous glucose production is inhibited by the adipose-derived protein Acrp30 (Q28366672) (← links)
- Berardinelli-seip congenital lipodystrophy 2/seipin is a cell-autonomous regulator of lipolysis essential for adipocyte differentiation (Q28513746) (← links)
- Altered lipid metabolism in residual white adipose tissues of Bscl2 deficient mice (Q28537585) (← links)
- Obesidomics: contribution of adipose tissue secretome analysis to obesity research (Q30414466) (← links)
- What's the matter with MAT? Marrow adipose tissue, metabolism, and skeletal health (Q33726338) (← links)
- The clinical approach to the detection of lipodystrophy - an AACE consensus statement (Q33939518) (← links)
- Lipodystrophy syndrome in HIV infection: what is it, what causes it and how can it be managed? (Q33983927) (← links)
- Mouse models of lipodystrophy (Q34107529) (← links)
- Monogenic Diabetes Secondary to Congenital Lipodystrophy in a 14-year-old Yemeni Girl-Case Report (Q34423253) (← links)
- Phenotypic heterogeneity in biochemical parameters correlates with mutations in AGPAT2 or Seipin genes among Berardinelli-Seip congenital lipodystrophy patients (Q34487883) (← links)
- Cardiomyopathy in congenital and acquired generalized lipodystrophy: a clinical assessment (Q34954748) (← links)
- Lipoatrophic diabetes and other related syndromes (Q35078482) (← links)
- Obesity, Metabolic Syndrome, and Adipocytes (Q35137702) (← links)
- Resolving the Two "Bony" Faces of PPAR-gamma. (Q35191573) (← links)
- Life without white fat: a transgenic mouse (Q35210661) (← links)
- Insulin resistance and diabetes mellitus in transgenic mice expressing nuclear SREBP-1c in adipose tissue: model for congenital generalized lipodystrophy (Q35210714) (← links)
- Diagnosing Friedreich's ataxia (Q35258617) (← links)
- Genotype-phenotype relationships in Berardinelli-Seip congenital lipodystrophy (Q35438358) (← links)
- Energy balance in congenital generalized lipodystrophy type I. (Q35674679) (← links)
- Seipin: from human disease to molecular mechanism (Q35958418) (← links)
- Berardinelli-Seip congenital lipodystrophy 2 regulates adipocyte lipolysis, browning, and energy balance in adult animals. (Q36093189) (← links)
- Berardinelli-Seip syndrome: highlight of treatment challenge (Q36704607) (← links)
- Motor neuron degeneration in a mouse model of seipinopathy. (Q36733211) (← links)
- Torpor in mice is induced by both leptin-dependent and -independent mechanisms (Q36750911) (← links)
- Molecular mechanisms of hepatic steatosis and insulin resistance in the AGPAT2-deficient mouse model of congenital generalized lipodystrophy (Q37171127) (← links)
- Repositioning HIV protease inhibitors as cancer therapeutics (Q37192579) (← links)
- Lipodystrophies: disorders of adipose tissue biology (Q37219869) (← links)
- Adipose proteome analysis: focus on mediators of insulin resistance (Q37352029) (← links)
- The human lipodystrophy gene product Berardinelli-Seip congenital lipodystrophy 2/seipin plays a key role in adipocyte differentiation (Q37369119) (← links)
- Dual-energy X-ray absorptiometry modeling to explain the increased resting energy expenditure associated with the HIV lipoatrophy syndrome (Q37421185) (← links)
- Clinical and Mutational Features of Three Chinese Children with Congenital Generalized Lipodystrophy (Q37717768) (← links)
- What the genetics of lipodystrophy can teach us about insulin resistance and diabetes (Q38136569) (← links)
- Congenital lipodystrophies and dyslipidemias (Q38232357) (← links)
- Congenital generalized lipodystrophies--new insights into metabolic dysfunction (Q38560271) (← links)
- Visfatin induces oxidative stress in differentiated C2C12 myotubes in an Akt- and MAPK-independent, NFkB-dependent manner. (Q39777377) (← links)
- Metabolic recovery of lipodystrophy, liver steatosis, and pancreatic β cell proliferation after the withdrawal of OSI-906. (Q41054274) (← links)
- Berardinelli Seip Syndrome (Q42062780) (← links)
- High prevalence of Berardinelli-Seip Congenital Lipodystrophy in Rio Grande do Norte State, Northeast Brazil. (Q42377398) (← links)
- Identification of a novel nonsense mutation and a missense substitution in the AGPAT2 gene causing congenital generalized lipodystrophy type 1. (Q42426413) (← links)
- Investigation of Lpin1 as a candidate gene for fat deposition in pigs (Q42660445) (← links)
- Molecular mechanisms underlying fasting modulated liver insulin sensitivity and metabolism in male lipodystrophic Bscl2/Seipin-deficient mice. (Q42945219) (← links)
- Berardinelli-Seip congenital lipodystrophy in two siblings (Q43052005) (← links)
- Growing interest in overgrowth (Q43102935) (← links)
- CILAIR-Based Secretome Analysis of Obese Visceral and Subcutaneous Adipose Tissues Reveals Distinctive ECM Remodeling and Inflammation Mediators (Q43170207) (← links)